Clinical Trials Logo

Clinical Trial Summary

This is a study to characterize the pharmacokinetics as well as safety and tolerability of a single oral dose of EDP-305 in subjects with mild and moderate hepatic impairment compared to matched healthy subjects.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03207425
Study type Interventional
Source Enanta Pharmaceuticals
Contact
Status Completed
Phase Phase 1
Start date June 14, 2017
Completion date September 19, 2017

See also
  Status Clinical Trial Phase
Recruiting NCT05479721 - LITMUS Imaging Study
Recruiting NCT06308757 - Role of the Very Low Calorie Ketogenic Diet (VLCKD) in Patients With Non-Alcoholic Steatohepatitis (NASH) With Fibrosis N/A
Completed NCT02923154 - Efficacy and Safety of MT-3995 in Patients With Non-Alcoholic Steatohepatitis(NASH) Phase 2
Withdrawn NCT03980912 - Validation of the LiverFASt Test and the Associated Fibrosis Staging Scores Compared to Liver Tissue Pathology Via Liver Biopsy
Terminated NCT04565717 - A Study of ALN-HSD in Healthy Adult Subjects and Adult Patients With Nonalcoholic Steatohepatitis (NASH) Phase 1
Not yet recruiting NCT05935488 - Early Liver Disease Breath Detection
Recruiting NCT04302051 - Assessment of Fatty Liver With Thermo-acoustic Device
Recruiting NCT05327127 - Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis Phase 2
Active, not recruiting NCT06315361 - DIAbetes and NAFLD
Completed NCT03187496 - Drug-drug Interaction Study Between EDP-305, Midazolam, Caffeine and Rosuvastatin in Healthy Volunteers. Phase 1
Recruiting NCT04442334 - The European NAFLD Registry
Recruiting NCT05193916 - A Phase II Clinical Trial of Chiglitazar for NASH Phase 2
Recruiting NCT05669677 - Study to Determine the Response to COVID-19 Vaccination and Prevalence of COVID-19 in Subjects With Chronic Liver Disease
Not yet recruiting NCT04783116 - Plant Stanols and Liver Inflammation in Overweight and Obese Children N/A
Recruiting NCT06193629 - A Multicenter, Double-blind, Placebo-randomized Controlled Clinical Study on the Treatment of Non-alcoholic Steatohepatitis With Tibetan Drug Langqing Atar N/A
Completed NCT04006145 - A Phase 2 Study of Elobixibat in Adults With NAFLD or NASH Phase 2
Recruiting NCT04232293 - Screening of Liver Fibrosis Using Blood Tests in Patients With Type 2 Diabetes Mellitus N/A
Not yet recruiting NCT04925362 - THE FRENCH NATIONAL NAFLD COHORT (FRench pAtients With MEtabolic Steatosis) N/A
Completed NCT05874336 - An Open-Label, Two-Part Study Designed to Assess the Absolute Bioavailability and Mass Balance of Aramchol Phase 1
Completed NCT04048135 - A Multiple Ascending Dose Study of BIO89-100 in Subjects With Biopsy Confirmed NASH or NAFLD and at High Risk of NASH Phase 1/Phase 2